Abstract: Parallel with bacteria and viruses, fungi are one of the three major pathogenic microorganisms in humans, which primarily infect immune-suppressed hosts. Since the founding of New China, great progress has been made in China's medical technology. A large number of internationally-level achievements have also been achieved in the prevention and clinical diagnosis and treatment of fungal diseases in China, which significantly improved the health of Chinese people. But we should be soberly aware that the improvement of medical level also brings a large number of long-term survival hosts in China, such as HIV-infected patients, patients after tumor radiotherapy and chemotherapy, etc. Moreover, high-virulence, multidrug-resistant pathogenic fungal isolates such as Candida auris (“super fungi”)- infections that caused by global exchanges and climate change have also been reported in many cities in China. Therefore, the future of prevention and treatment of important fungal diseases in China is still a long way to go. There is an urgent need to strengthen the collaboration between clinical disciplines and basic disciplines such as medical mycology and epidemiology and related companies. Particularly the epidemiology, pathogenesis, transformation of mycosis, and cooperation in production, education and research should be strengthen, striving to build a key technical system for the prevention, diagnosis and treatment of important fungal diseases at an early stage, and providing the world with clinical diagnostic criteria for mycosis with Chinese characteristics, which will significantly contribute to the prevention and treatment of important fungal diseases in China.

Key words: Mycoses, Precaution, Diagnosis, Treatment, Strategy